Fennec Pharmaceuticals (FENC)

Fennec Pharmaceuticals (FENC) Cash flow


Fennec Pharmaceuticals Cash Flow

FENC's free cash flow for Q4 2023 was $-4.86M. For the 2023 fiscal year, FENC's free cash flow was decreased by $-17.14M and operating cash flow was $-4.86M. See a summary of the company’s cash flow.
Cash Flow
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -14.38M$ -17.14M$ -18.06M$ -14.22M$ -15.60M$ -9.06M
Investing Cash Flow
Financing Cash Flow
$ 6.44M$ 6.64M$ 20.73M$ 4.98M$ 32.29M$ -71.00K
Cash Flow From Discontinued Operation
Other Cash Adjustment Inside Changein Cash
End Cash Position
$ 59.02M$ 13.27M$ 23.77M$ 21.10M$ 30.34M$ 13.65M
Income Tax Paid Supplemental Data
Interest Paid Supplemental Data
Issuance Of Capital Stock
---$ 0.00$ 31.97M$ 0.00
Issuance Of Debt
$ 5.00M$ 5.00M$ 20.00M$ 5.00M$ 0.00-
Repayment Of Debt
Free Cash Flow
$ -14.38M$ -17.14M-$ -14.22M$ -15.60M$ -9.06M
Domestic Sales
Foreign Sales
Currency in USD

Fennec Pharmaceuticals Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis